Target intelligence / Profile preview

Host Cellular Systems

Molecular classification
Other
01

Overview

Host cellular systems encompass the complex network of molecular pathways, organelles, and biochemical processes within a host cell that maintain homeostasis and respond to external stimuli. In the context of pharmacology and infectious diseases, these systems are often exploited by pathogens for entry, replication, and egress (Zumla et al., 2016, The Lancet Infectious Diseases). Host-directed therapies (HDTs) aim to modulate these endogenous pathways—such as the immune response, autophagy, or metabolic signaling—to combat infections or treat chronic diseases like cancer and inflammation (Kaufmann et al., 2018, Nature Reviews Drug Discovery). By targeting host factors rather than the pathogen itself, this approach can potentially reduce the development of drug resistance and provide broad-spectrum efficacy. However, because these systems are essential for normal physiological function, therapeutic intervention requires precise targeting to avoid significant toxicity or systemic side effects (NIH, 2023).

Other names
Host cell machineryHost factorsHost-directed targetsEndogenous cellular pathways
02

Mechanism of action

Host-directed therapy (HDT) involves the modulation of host cell components or pathways to enhance host defense mechanisms, limit pathogen replication, or control excessive inflammatory responses (Kaufmann et al., 2018, Nature Reviews Drug Discovery).

03

Biological functions

Signal transductionImmune responseMetabolismCell cycleApoptosisProtein synthesisAutophagy
04

Disease associations

InfectionCancerInflammationAutoimmune diseaseMetabolic disorder
05

Safety considerations

Potential for systemic toxicityRisk of immunosuppressionInterference with essential physiological processesOff-target effectsDisruption of cellular homeostasis
06

Interacting drugs

Maraviroc

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)ProcalcitoninInterferon-gamma (IFN-gamma)Tumor necrosis factor-alpha (TNF-alpha)

Beyond the preview

Go deeper on Host Cellular Systems.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host Cellular Systems.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call